Opus Genetics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
IRD on Nasdaq
Industry
Pharmaceutical Preparations
Location
8 Davis Drive, Suite 220, Durham, NC

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other*, 10%+ Owner $8.45M May 5, 2025
Cam Gallagher Director $2.08M Aug 25, 2025
George Magrath Chief Executive Officer, Director $1.52M +$199K +15% Mar 24, 2025
Benjamin R. Yerxa President, Director $337K +$9.83K +3% Nov 21, 2024
Jay Pepose Director $319K Jun 11, 2024
Ronil A. Patel Chief Business Officer $296K Jan 10, 2024
Sean Ainsworth Director $293K Aug 25, 2025
Richard J. Rodgers Director $284K Apr 30, 2025
S. Manuso James Director $233K Apr 30, 2025
Nirav S. Jhaveri Chief Financial Officer $223K Mar 13, 2025
Bernhard Hoffmann SVP of Corp. Dev. $213K Mar 13, 2025
Susan Benton Director $195K Apr 30, 2025
Robert E. Gagnon Chief Financial Officer $192K Sep 2, 2025
Jean Bennett Director $190K Apr 30, 2025
Mina Sooch President and CEO, Director $163K Jan 10, 2023
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $145K Mar 13, 2025
Rabourn Amy Zaremba SVP of Finance $131K Mar 13, 2025
Adrienne L. Graves Director $70.8K Apr 30, 2025
Joseph K. Schachle Chief Operating Officer $62.7K Mar 13, 2025

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.